1. Home
  2. SOPH vs PROF Comparison

SOPH vs PROF Comparison

Compare SOPH & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$4.99

Market Cap

374.1M

Sector

Health Care

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.88

Market Cap

243.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
PROF
Founded
2011
N/A
Country
Switzerland
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
374.1M
243.2M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
SOPH
PROF
Price
$4.99
$6.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.50
$12.00
AVG Volume (30 Days)
87.4K
61.0K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
0.19
Revenue
N/A
$16,098,000.00
Revenue This Year
$23.09
$92.40
Revenue Next Year
$19.57
$64.10
P/E Ratio
N/A
$35.95
Revenue Growth
N/A
50.73
52 Week Low
$2.59
$3.92
52 Week High
$5.70
$8.95

Technical Indicators

Market Signals
Indicator
SOPH
PROF
Relative Strength Index (RSI) 51.97 50.78
Support Level $4.54 $5.81
Resistance Level $5.46 $7.07
Average True Range (ATR) 0.37 0.38
MACD 0.01 -0.05
Stochastic Oscillator 43.81 23.67

Price Performance

Historical Comparison
SOPH
PROF

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: